13Mar 2025
COVID-19 Vaccination and Chemoradiotherapy Outcomes in Nasopharyngeal Carcinoma

COVID-19 Vaccination and Chemoradiotherapy Outcomes in Nasopharyngeal Carcinoma

COVID-19 vaccination increases TRAEs but does not impact NPC outcomes. A study of 893 nonmetastatic NPC patients found higher neutropenia (p=0.045) and fatigue (p=0.010) post-vaccination during chemotherapy, with increased fatigue (p=0.015) during radiotherapy. However, 2-year OS, PFS, DMFS, and LRRFS remained unaffected. Vaccinated patients also maintained a high, stable lymphocyte count. These findings suggest vaccination is safe but may heighten acute treatment-related adverse events.

  • #ent

Like

Save

Share